Drugs for Tatton-Brown-Rahman Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 2200)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Nutmeg |
Approved |
Phase 4 |
|
|
|
Synonyms:
|
2 |
|
Norethisterone |
Approved |
Phase 4 |
|
68-22-4 |
199472 6230 |
Synonyms:
(-)-Gallocatechin gallic acid
(-)-Gallocatechin-3-O-gallate
(-)-Gallocatechin-3-O-gallic acid
(-)-Gallocatechol gallate
(-)-Gallocatechol gallic acid
(17a)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one
(17Α)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoic acid)
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoic acid
17a-Ethinyl-19-nortestosterone
17a-Ethinylestra-4-en-17b-ol-3-one
17a-Ethynyl-17b-hydroxy-19-norandrost-4-en-3-one
17a-Ethynyl-17-hydroxy-4-estren-3-one
17-a-Ethynyl-17-hydroxy-4-estren-3-one
17a-Ethynyl-19-nor-4-androsten-17b-ol-3-one
17a-Ethynyl-19-norandrost-4-en-17b-ol-3-one
17-a-Ethynyl-19-norandrost-4-en-17-b-ol-3-one
17a-Ethynyl-19-nortestosterone
17-a-Ethynyl-19-nortestosterone
17a-Ethynyl-4-estren-17-ol-3-one
17-a-Ethynyl-4-estren-17-ol-3-one
17alpha-Ethinyl-17alpha-ethinyl-19-nortestosterone
17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinylestra-4-en-17beta-ol-3-one
17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one
17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one
17alpha-Ethynyl-17-hydroxy-4-estren-3-one
17-alpha-Ethynyl-17-hydroxy-4-estren-3-one
17alpha-Ethynyl-17-hydroxyest-4-en-3-one
17alpha-Ethynyl-17-hydroxy-estr-4-en-3-one
17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one
17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one
17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one
17alpha-Ethynyl-19-nortestosterone
17-alpha-Ethynyl-19-nortestosterone
17alpha-Ethynyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-4-estren-17-ol-3-one
17-alpha-Ethynyl-4-estren-17-ol-3-one
17alpha-Pregn-4-en-20-yn-3-one
17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one
17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-Ethinyl-19-nor-testosterone
17-Ethynyl-17beta-hydroxyestr-4-en-3-one
17-Ethynyl-17-hydroxyestr-4-en-3-one (acd/name 4.0)
17-Ethynyl-19-nortestosterone
17-Hydroxy-(17alpha)-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-α-pregn-4-en-20-yn-3-one
17Α-ethinyl-19-nortestosterone
17Α-ethinylestra-4-en-17β-ol-3-one
17Α-ethynyl-17-hydroxy-4-estren-3-one
17-Α-ethynyl-17-hydroxy-4-estren-3-one
17Α-ethynyl-17β-hydroxy-19-norandrost-4-en-3-one
17Α-ethynyl-19-nor-4-androsten-17β-ol-3-one
17Α-ethynyl-19-norandrost-4-en-17β-ol-3-one
17-Α-ethynyl-19-norandrost-4-en-17-β-ol-3-one
17Α-ethynyl-19-nortestosterone
17-Α-ethynyl-19-nortestosterone
17Α-ethynyl-4-estren-17-ol-3-one
17-Α-ethynyl-4-estren-17-ol-3-one
17Β-hydroxy-19-norpregn-4-en-20-yn-3-one
17-Β-hydroxy-19-norpregn-4-en-20-yn-3-one
19-Nor-17a-ethynyl-17b-hydroxy-4-androsten-3-one
19-Nor-17-a-ethynyl-17-b-hydroxy-4-androsten-3-one
19-Nor-17a-ethynylandrosten-17b-ol-3-one
19-Nor-17-a-ethynylandrosten-17-b-ol-3-one
19-Nor-17a-ethynyltestosterone
19-Nor-17-a-ethynyltestosterone
19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one
19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one
|
19-Nor-17alpha-ethynyltestosterone
19-Nor-17-alpha-ethynyltestosterone
19-Nor-17-ethinyltestosterone
19-Nor-17α-ethynyl-17β-hydroxy-4-androsten-3-one
19-Nor-17-α-ethynyl-17-β-hydroxy-4-androsten-3-one
19-Nor-17α-ethynylandrosten-17β-ol-3-one
19-Nor-17-α-ethynylandrosten-17-β-ol-3-one
19-Nor-17α-ethynyltestosterone
19-Nor-17-α-ethynyltestosterone
19-Nor-ethindrone
19-Norethinyltestosterone
19-Norethisterone
4-Estren-17a-ethynyl-17b-ol-3-one
4-Estren-17alpha-ethynyl-17beta-ol-3-one
4-Estren-17α-ethynyl-17β-ol-3-one
ACTIVELLA
Anhydrohydroxynorprogesterone
Anovule
AYGESTIN
Camila
COMBIPATCH
Conceplan
Conludaf
Conludag
ENT
ent-Gallocatechin 3-gallic acid
ERRIN
Ethinyl-19-nortestosterone
Ethinylnortestosterone
Ethynylnortestosterone
FEMHRT
Gallocatechin gallate
Gallocatechin-3-gallate
Gestest
HEATHER
INCASSIA
JENCYCLA
Menzol
Micronett
Micronor
MICRONOR HRT
Micronor®|norethindrone|Noriday®
Micronovum
Mini-pe
Mini-pill
Minovlar
Monogest
NEA713
NET
Nor QD
Noralutin
Norcolut
Norcolute
Noresthisterone
NORETHIDRONE
Norethindrone
Norethindrone, (1 beta)-isomer
Norethisteron
Norethisterone
Noréthistérone
Norethisteronum
Norethyndron
Norethynodrone
Noretisterona
Norfor
Norgestin
Noriday
Norlutate
Norluten
Norlutin
Norluton
Normapause
Norpregneninlone
Norpregneninolone
Nor-q.d.
NorQD
Nor-QD
NSC-9564
Primolut N
Primolut-N
Proluteasi
SC-4640
Utovlan
Utovlar
|
|
3 |
|
Teicoplanin |
Approved, Investigational |
Phase 4 |
|
61036-62-2 |
16170201 |
Synonyms:
22-Amino-5,15-dichloro-64-({4,5-dihydroxy-3-[(1-hydroxydecylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-2-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-21,26,31,35,38,44,49,54,56,59-decahydroxy-47-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7,13,28-trioxa-20,36,39,53,55,58-hexaazaundecacyclo[38.14.2.2,.2,.2,.1,.1,.1,.1,.0,.0,]hexahexaconta-3,5,8,10,12(64),14,16,20,23(61),24,26,29(60),30,32,35,38,41(57),42,44,46(51),47,49,53,55,58,62,65-heptacosaene-52-carboxylate
MDL-507
TARGOCID
Teichomycin A2
|
TEICOPLANIN
teicoplanina
téicoplanine
teicoplaninum
|
|
4 |
|
Copper |
Approved, Investigational |
Phase 4 |
|
7440-50-8 |
27099 |
Synonyms:
cobre
COPPER (II) ion
Copper(II) cation
Copper, ion (cu2+)
Cu
Cu(2+)
|
Cu(II)
Cu2+
cuivre
Cupric ion
cuprum
Kupfer
|
|
5 |
|
Gatifloxacin |
Approved, Investigational, Withdrawn |
Phase 4 |
|
112811-59-3 |
5379 |
Synonyms:
1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylate
1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylate
1-Cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid
AM 1155
AM-1155
BMS-20658401
BMS-206584-01
GATIFLOXACIN
Gatifloxacin anhydrous
|
GATIFLOXACIN HYDRATE
GATIFLOXACIN SESQUIHYDRATE
Gatifloxacine
Gatifloxacino
Gatifloxacinum
PD-135432
Tequin
Zymar
ZYMAXID
Zymer
|
|
6 |
|
Ciclopirox |
Approved, Investigational |
Phase 4 |
|
29342-05-0 |
2749 |
Synonyms:
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt
Batrafen
Ciclodan®|HOE-296|HOE-296b|Loprox®
CICLOPIROX
Ciclopirox olamin
Ciclopirox olamine
Ciclopirox-olamin
Ciclopiroxolamine
Ciclopiroxum
|
Cyclopirox
Cyclopyroxolamine
Dafnegin CSC
Dafnegin-CSC
HOE 296
HOE 296b
HOE-296
HOE-296b
Loprox
Penlac
|
|
7 |
|
Tirofiban |
Approved |
Phase 4 |
|
144494-65-5 |
60947 |
Synonyms:
(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoate
(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid
(2S)-2-(Butylsulphonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoate
(2S)-2-(Butylsulphonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid
Aggrastat
Aggrastat®|L-700462|MK-383|tirofiban hydrochloride (monohydrate)
Agrastat
Cahill may roberts brand OF tirofiban hydrochloride monohydrate
L-700462
Merck brand OF tirofiban hydrochloride monohydrate
Merck frosst brand OF tirofiban hydrochloride monohydrate
|
Merck sharp and dohme brand OF tirofiban hydrochloride monohydrate
MK-383
MSD Brand OF tirofiban hydrochloride monohydrate
N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine
N-(BUTYLSULFONYL)-O-[4-(4-PIPERIDYL)BUTYL]-L-TYROSINE
N-(Butylsulphonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine
TIROFIBAN
Tirofibán
Tirofiban hydrochloride
Tirofiban hydrochloride monohydrate
Tirofibanum
|
|
8 |
|
Chloral hydrate |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
302-17-0 |
2707 |
Synonyms:
1,1,1-Trichloro-2,2-dihydroxyethane
1,1,1-Trichloro-2,2-ethanediol
2,2,2-Trichloro-1,1-ethanediol
Aquachloral supprettes
Chloral hydrate
Chloral hydric acid
Chloral monohydrate
Chloral monohydric acid
|
Chloralhydrat
Hydrate, chloral
Knockout drops
Noctec
Somnote
Trichloracetaldehyd-hydrat
Trichloroacetaldehyde hydrate
Trichloroacetaldehyde hydric acid
|
|
9 |
|
Etomidate |
Approved |
Phase 4 |
|
33125-97-2 |
667484 |
Synonyms:
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylic acid
(+)-Ethyl 1-(a-methylbenzyl)imidazole-5-carboxylate
(+)-Ethyl 1-(a-methylbenzyl)imidazole-5-carboxylic acid
(+)-Ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate
(+)-Ethyl 1-(α-methylbenzyl)imidazole-5-carboxylic acid
(+)-Etomidate
(+)-Etomidic acid
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylate ethyl ester
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-(+)-1-(a-Methylbenzyl)imidazole-5-carboxylate ethyl ester
(R)-(+)-1-(a-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-(+)-1-(Α-methylbenzyl)imidazole-5-carboxylate ethyl ester
(R)-(+)-1-(Α-methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylate ethyl ester
|
(R)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylate ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
AMIDATE
D-ETOMIDATE
Ethomidate
ETOMIDATE
Etomidato
Etomidatum
Etomidic acid
Hypnomidate
R 16659
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid
Radenarkon
|
|
10 |
|
Rabeprazole |
Approved, Investigational |
Phase 4 |
|
117976-89-3, 117976-90-6 |
5029 |
Synonyms:
1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt
2-((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole
Aciphex
ACIPHEX SPRINKLE
Clofezone
Dexrabeprazole
E3810
E-3810
E-3810 (PPI)
E-3810 SODIUM
Eraloc
Habeprazole
Irsogladine Maleate
|
LY307640
LY-307640
LY307640 SODIUM
LY-307640 SODIUM
Pariet
Pariets
RABEPRAZOLE
Rabeprazole sodium
RABEPRAZOLE SODIUM SALT
Rebeprazole sodium
Sodium rabeprazole
Sodium, rabeprazole
|
|
11 |
|
Oxytocin |
Approved, Vet_approved |
Phase 4 |
|
50-56-6 |
439302 53477758 |
Synonyms:
(2S)-2-[({1-[(4R,7S,10S,13S,16S,19R)-19-amino-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentahydroxy-10-[2-(C-hydroxycarbonimidoyl)ethyl]-7-[(C-hydroxycarbonimidoyl)methyl]-16-[(4-hydroxyphenyl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-N-[(C-hydroxycarbonimidoyl)methyl]-4-methylpentanimidate
(Arg8)-vasopressin
(Arg8)-vasotocin
[<sup>3</sup>H]oxytocin
alpha-Hypophamine
Argipressin
Argpressin acetate
Biotinyl-(arg8)-vasopressin
Cys-tyr-ile-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-ile-GLN-asn-cys-pro-leu-gly-NH2
Cys-tyr-ile-THR-asn-cys-gly-leu-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-lys-gly-NH2
Disulfide bridge cys1-cys6
Gly-leu-pro-c
Ocytocin
|
ORASTHIN
Oxitocina
OXT
OXYTOCIN
Oxytocin 10 usp units in dextrose 5%
Oxytocin 20 usp units in dextrose 5%
Oxytocin 5 usp units in dextrose 5%
Oxytocin acetate
Oxytocin injection
PITOCIN
SID29217903
SID50111741
SYNTOCINON
SYNTOMETRINE
SYT670
TTA-121
|
|
12 |
|
Telmisartan |
Approved, Investigational |
Phase 4 |
|
144701-48-4 |
65999 |
Synonyms:
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylate
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylate
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylate
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylate
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
BIBR 277
BIBR 277Se
BIBR-277
|
BIBR-277 SE
BIBR-277SE
BIBR-277-SE
BIBR-277SE|Kinzalmono®|Micardis®|Pritor®
C09CA07
Micardis
Micardis HCT
Pritor
TELMISARTAN
Telmisartan tablets
TOLURA
|
|
13 |
|
Benserazide |
Approved, Investigational |
Phase 4 |
|
322-35-0 |
2327 |
Synonyms:
Benserazida
BENSERAZIDE
BENSERAZIDE HCL
Benserazidum
Benzylhydrazine, seryltrihydroxy
DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide
DL-Serine 2-(2,3,4-trihydroxybenzyl)hydrazide
DL-Serine 2-[(2,3,4-trihydroxyphenyl)methyl]hydrazide
MADOPAR
|
Madopar®|Ro 4-4602|serazide
Ro 44602
Ro 4-4602
RO-44602
RO-4-4602
Serazide
Seryltrihydroxy benzylhydrazine
Seryltrihydroxybenzylhydrazine
|
|
14 |
|
Simeprevir |
Approved |
Phase 4 |
|
923604-59-5 |
66811198 24873435 66576988 |
Synonyms:
435, TMC
N-(17-(2-(4-Isopropylthiazole-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo(13.3.0.04,6)octadec-7-ene-4-carbonyl)(cyclopropyl)sulfonamide
N-(Cyclopropanesulfonyl)-2-hydroxy-17-({7-methoxy-8-methyl-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-13-methyl-14-oxo-3,13-diazatricyclo[13.3.0.0,]octadeca-2,7-diene-4-carboximidate
N-(Cyclopropanesulphonyl)-2-hydroxy-17-({7-methoxy-8-methyl-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-13-methyl-14-oxo-3,13-diazatricyclo[13.3.0.0,]octadeca-2,7-diene-4-carboximidate
N-(Cyclopropanesulphonyl)-2-hydroxy-17-({7-methoxy-8-methyl-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-13-methyl-14-oxo-3,13-diazatricyclo[13.3.0.0,]octadeca-2,7-diene-4-carboximidic acid
Olysio
SIMEPREVIR
|
SIMEPREVIR SODIUM
TMC 435
TMC 435350
TMC435
TMC-435
TMC435350
TMC-435350
|
|
15 |
|
Tiotropium |
Approved |
Phase 4 |
|
136310-93-5, 186691-13-4 |
3086655 5487427 5487426 |
Synonyms:
679 BR, BA
7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide
BA 679 BR
BA679 BR
BA-679 BR
BA-679BR
BA-679-BR
BA-679-BR|Spiriva®
BR, BA 679
|
BRALTUS
Bromide, tiotropium
Spiriva
SPIRIVA RESPIMAT
TIOTROPIUM
Tiotropium bromide
TIOTROPIUM BROMIDE HYDRATE
TIOTROPIUM BROMIDE MONOHYDRATE
|
|
16 |
|
Glyburide |
Approved |
Phase 4 |
|
10238-21-8 |
3488 |
Synonyms:
1-((p-(2-(5-Chloro-O-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-((p-(2-(5-Chloro-O-anisamido)ethyl)phenyl)sulphonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulphonyl)-3-cyclohexylurea
5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide
5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulphonyl)phenyl)ethyl)-2-methoxybenzamide
Abbenclamide
Adiab
Amglidia®|Diabeta®|glyburide|Glynase®
Apo-glibenclamide
Azuglucon
Bastiverit
Benclamin
Betanase
Betanese 5
CALABREN
Cytagon
Daonil
Debtan
Dia-basan
Diabeta
DIABETAMIDE 2.5
DIABETAMIDE 5
Diabiphage
Dibelet
Duraglucon
Euclamin
Euglucan
EUGLUCON
Euglucon 5
Euglucon N
Euglykon
GBN 5
Gen-Glybe
Gewaglucon
Gilemal
Glamide
Glibadone
Gliban
Gliben
Glibenbeta
Glibenclamid AL
Glibenclamid Basics
Glibenclamid Fabra
Glibenclamid Genericon
Glibenclamid Heumann
Glibenclamid Riker M.
Glibenclamida
Glibenclamida [INN-Spanish]
Glibenclamid-Cophar
Glibenclamide
Glibenclamid-Ratiopharm
Glibenclamidum
Glibenclamidum [INN-Latin]
Glibenil
Gliben-Puren N
Glibens
Glibesyn
Glibet
Glibetic
|
Glibil
Gliboral
Glicem
Glidiabet
GLIKEN
Glimel
Glimide
Glimidstata
Glisulin
Glitisol
Glubate
Gluben
Glucobene
Glucohexal
Glucolon
Glucomid
Glucoremed
Gluco-Tablimen
Glucoven
Glyben
Glybenclamide
Glybenzcyclamide
GLYBURIDE
GLYBURIDE (MICRONIZED)
Glycolande
Glycomin
Glynase
GLYNASE PRESTAB
HB 419
HB-419
Hexaglucon
Humedia
LEDERGLIB
LIBANIL
Lisaglucon
MALIX
Maninil
Med-Glionil
Melix
Micronase
Miglucan
Nadib
Neogluconin
Norglicem 5
Normoglucon
Novo-Glyburide
Orabetic
Pira
Praeciglucon
PresTab
Prodiabet
Renabetic
SEMI-DAONIL
Sugril
Suraben
Tiabet
U-26,45
U-26452
Yuglucon
|
|
17 |
|
Budesonide |
Approved |
Phase 4 |
|
51333-22-3 |
5281004 40000 63006 |
Synonyms:
(11b,16a)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11Β,16α)-16,17-(butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
AIRCORT
Bidien
BUDEFLAM AQUANASE
BUDELIN NOVOLIZER
BUDENOFALK
Budeson
Budesónida
BUDESONIDE
Budesonide, (R)-isomer
Budesonide, (S)-isomer
Budicort
CORTIMENT
Cortivent
Desowen
DEXBUDESONIDE
DUORESP SPIROMAX
ENTOCORT
ENTOCORT CR
Entocort ec
Entocort®|Eohilia® (budesonide oral suspension)|Jorveza®|Pulmicort®|S-1320|Uceris®
Horacort
MAP0010
|
MAP-0010
Micronyl
Noex
ORTIKOS
PREFERID
PULMAXAN
Pulmicort
PULMICORT FLEXHALER
PULMICORT L.S.
Pulmicort Nebuamp
PULMICORT RESPULES
Pulmicort Turbuhaler
R01AD05
Rhinocort
RHINOCORT ALLERGY
RHINOCORT AQUA
RHINOCORT AQUA 64
Rhinocort Turbuhaler
Rhinosol
S-1320
Spirocort
SYMBICORT
Tridesilon
Uceris
|
|
18 |
|
Deflazacort |
Approved, Investigational |
Phase 4 |
|
14484-47-0 |
26709 189821 |
Synonyms:
2-{11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.0,.0,.0,]icosa-6,14,17-trien-8-yl}-2-oxoethyl acetic acid
CALCORT
DEFLAZACORT
EMFLAZA
|
|
|
19 |
|
Olodaterol |
Approved |
Phase 4 |
|
868049-49-4 |
9800339 11504295 |
Synonyms:
BI 1744
BI-1744
BI-1744|BI-1744-CL|Striverdi®
BI-1744-CL
|
OLODATEROL
STRIVERDI
STRIVERDI RESPIMAT
|
|
20 |
|
Tadalafil |
Approved, Investigational |
Phase 4 |
|
171596-29-5 |
110635 |
Synonyms:
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
351, IC
6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
Adcirca
Adcirca®|Cialis®|IC-351|IC351
Cialis
|
IC351
IC-351
ICOS 351
Tadalafil
Tadalafilo
Tadanafil
Zalutia
|
|
21 |
|
Mometasone furoate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
83919-23-7 |
4240 441336 |
Synonyms:
(9BETA,10ALPHA,11ALPHA,14BETA,16ALPHA,17ALPHA)-9,21-DICHLORO-11-HYDROXY-16-METHYL-3,20-DIOXOPREGNA-1,4-DIEN-17-YL FURAN-2-CARBOXYLATE
ASMANEX
ASMANEX HFA
ASMANEX TWISTHALER
ELOCON
MOMETASONE
MOMETASONE 17-FUROATE
|
MOMETASONE FUROATE
Mometasone furoate anhydrous
MOMETASONE FUROATE MONOHYDRATE
Mometasone furoic acid
NASONEX
SCH-32088
SINUVA
|
|
22 |
|
Famotidine |
Approved |
Phase 4 |
|
76824-35-6 |
3325 5702160 |
Synonyms:
(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide
(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulphamide
3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide
3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulphonyl)propanimidamide
3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine
3-{[(2-CARBAMIMIDAMIDO-1,3-THIAZOL-4-YL)METHYL]SULFANYL}-N-SULFAMOYLPROPANIMIDAMIDE
Amfamox
Antodine
Apo-famotidine
Apogastine
Bestidine
Blocacid
Brolin
Cepal
Confobos
Cronol
Cuantin
Famocid
Famodar
Famodil
Famodin
Famodine
Famogard
Famonit
Famopsin
Famos
Famosan
Famotal
Famotep
Famotidina
Famotidine
Famotidine hydrochloride
FAMOTIDINE PRESERVATIVE FREE
Famotidinum
Famotin
Famovane
Famowal
Fluxid
GASTER
Gaster®|MK-208|Pepcid®
Gastridan
Gastridin
Gastrion
Gastro
Gastrodomina
Gastrofam
Gastropen
Gastrosidin
Hacip
Huberdina
Ingastri
Invigan
|
L 643341
Lecedil
Logos
Mensoma
Midefam
MK-208
Mosul
Motiax
Muclox
Mylanta ar
Neocidine
Nevofam
Notidin
Novo-famotidine
N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide
N-Sulphamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide
Nulceran
Nulcerin
Panalba
Pepcid
PEPCID AC
PEPCID PRESERVATIVE FREE
PEPCID RPD
Pepcidin
Pepcidin pepcidine
PEPCIDIN PEPCIDINE
Pepdine
Pepdul
Pepfamin
Peptan
Peptidin
Purifam
Quamatel
Quamtel
Renapepsa
Restadin
Rogasti
Rubacina
Tamin
Tipodex
Topcid
Ulcatif
Ulceprax
Ulcofam
Ulfagel
Ulfam
Ulfamid
Ulfinol
Ulgarine
Vagostal
YM-11170
|
|
23 |
|
Hydrotalcite |
Approved, Experimental, Investigational |
Phase 4 |
|
12304-65-3 |
|
Synonyms:
|
24 |
|
Theophylline |
Approved |
Phase 4 |
|
58-55-9 |
2153 |
Synonyms:
1,3 Dimethylxanthine
1,3-DIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3-Dimethyl-7H-purine-2,6-dione
1,3-Dimethylxanthine
3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione
Accurbron
Acet-theocin
Aerobin
Aerolate
Aerolate III
AEROLATE JR
Aerolate SR
Afonilum retard
Aminophylline
Anhydrous, theophylline
Aquaphyllin
Armophylline
Asbron
Asmax
Austyn
Bronchoparat
Bronkodyl
Bronkodyl SR
Choledyl sa
Constant T
ConstantT
Constant-T
CT Arzneimittel brand OF theophylline sodium glycinate
CT, Theo von
CT-Arzneimittel brand OF theophylline sodium glycinate
DIMETHYLXANTHINE
Diphyllin
Doraphyllin
Duraphyl
Dyspne-inhal
Elixex
Elixicon
Elixomin
Elixophyllin
Elixophyllin SR
Elixophylline
Euphylline
Euphylong
Fameasan brand OF theophylline sodium glycinate
Fujisawa brand OF theophylline sodium glycinate
Glycinate, theophylline sodium
Glycine theophyllinate
Labid
Lanophyllin
LASMA
Liquophylline
Liquorice
Lodrane
Maphylline
Medaphyllin
Monospan
Mundipharma brand OF theophylline sodium glycinate
NSC-2066
Nuelin
Nuelin s.a.
NUELIN SA
NUELIN SA-250
Nuelin®|Slo-Bid®|Theolair®
Optiphyllin
Parkophyllin
PRO-VENT
Pseudotheophylline
QUIBRON
Quibron T SR
Quibron t/sr
Quibron TSR
Quibron T-SR
Quibron-t
Quibron-t/sr
Respbid
Slo phyllin
Slo-bid
Slo-phyllin
SloPhyllin
|
Sodium glycinate, theophylline
Solosin
Somophyllin T
Somophyllin-CRT
Somophyllin-DF
SomophyllinT
Somophyllin-T
Spophyllin retard
Sustaire
Synophylate
Synophylate-l.a. cenules
Tefamin
Teofilina
Teofyllamin
Teolair
Theacitin
Theal tabl.
Theal tablets
Theo 24
Theo dur
Theo von CT
Theo24
Theo-24
Theobid
Theobid jr.
Theochron
Theocin
Theoclair-SR
Theoclear 80
Theoclear l.a.-130
THEOCLEAR L.A.-260
Theoclear la
THEOCLEAR-100
Theoclear-200
Theoclear-80
Theoconfin continuous
Theocontin
Theodel
Theodur
Theo-dur
Theodur g
Theo-dur-sprinkle
Theofol
Theograd
Theolair
Theolair-SR
Theolix
Theolixir
Theon
Theona p
Theonite
Theopek
Theophyl
Theophyl-225
Theophyline
Theophyllin
Theophyllinate, glycine
THEOPHYLLINE
Theophylline anhydrous
THEOPHYLLINE MELTING POINT STANDARD
THEOPHYLLINE MONOHYDRATE
Theophylline sodium glycinate
THEOPHYLLINE, ANHYDROUS
Theophylline-SR
Theophyl-SR
Theospan
Theostat
Theostat 80
Theovent
T-Phyl
Uni-dur
Unifyl
Uniphyl
Uniphyllin
UNIPHYLLIN CONTINUS
Uniphylline
Von CT, theo
Xanthium
Xantivent
|
|
25 |
|
Deoxycholic acid |
Approved |
Phase 4 |
|
83-44-3 |
222528 |
Synonyms:
(3a,5a,12a)-3,12-DIHYDROXYCHOLAN-24-Oate
(3a,5a,12a)-3,12-DIHYDROXYCHOLAN-24-Oic acid
(3a,5b,12a)-3,12-Dihydroxycholan-24-Oate
(3a,5b,12a)-3,12-Dihydroxycholan-24-Oic acid
(3alpha,5alpha,12alpha)-3,12-DIHYDROXYCHOLAN-24-Oate
(3ALPHA,5ALPHA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID
(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-Oate
(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-Oic acid
(3Α,5α,12α)-3,12-dihydroxycholan-24-Oate
(3Α,5α,12α)-3,12-dihydroxycholan-24-Oic acid
(3Α,5β,12α)-3,12-dihydroxycholan-24-Oate
(3Α,5β,12α)-3,12-dihydroxycholan-24-Oic acid
12beta-Isomer deoxycholic acid
3a,12a-Dihydroxy-5b-cholanate
3a,12a-Dihydroxy-5b-cholanic acid
3alpha,12alpha-Dihydroxy-5beta-cholanate
3alpha,12alpha-Dihydroxy-5beta-cholanic acid
3beta-Isomer deoxycholic acid
3Α,12α-dihydroxy-5β-cholanate
3Α,12α-dihydroxy-5β-cholanic acid
5alpha-Isomer deoxycholic acid
5b-Cholanic acid-3a,12a-diol
5b-Deoxycholate
5b-Deoxycholic acid
7a-Deoxycholate
7a-Deoxycholic acid
7alpha-Deoxycholate
7alpha-Deoxycholic acid
7-Deoxycholate
7-Deoxycholic acid
7Α-deoxycholate
7Α-deoxycholic acid
Acid, 5alpha-isomer deoxycholic
Acid, choleic
Acid, deoxycholic
Acid, desoxycholic
Acid, dihydroxycholanoic
|
Acid, lagodeoxycholic
ATX-101
ATX-101|DCA|deoxycholate
Choleic acid
Cholerebic
Cholorebic
Degalol
Deoxycholatate
Deoxycholate
Deoxy-cholate
Deoxycholate, sodium
Deoxycholatic acid
Deoxycholic acid
Deoxy-cholic acid
Deoxycholic acid, 12beta isomer
Deoxycholic acid, 12beta-isomer
Deoxycholic acid, 3beta isomer
Deoxycholic acid, 3beta-isomer
Deoxycholic acid, 5alpha isomer
Deoxycholic acid, 5alpha-isomer
Deoxycholic acid, disodium salt
Deoxycholic acid, magnesium (2:1) salt
Deoxycholic acid, monoammonium salt
Deoxycholic acid, monopotassium salt
Deoxycholic acid, monosodium salt
Deoxycholic acid, sodium salt, 12beta-isomer
Desoxycholate
Desoxycholic acid
Desoxycholsaeure
Desoxycholsäure
Dihydroxycholanoic acid
DWJ211
DWJ-211
KYBELLA
Lagodeoxycholic acid
NSC-8797
Sodium deoxycholate
|
|
26 |
|
Simvastatin |
Approved |
Phase 4 |
|
79902-63-9 |
54454 |
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8AR)-8-{2-[(2R,4R)-4-HYDROXY-6-OXOOXAN-2-YL]ETHYL}-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2,2-DIMETHYLBUTANOATE
2,2-Dimethylbutyrate, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
C10AA01
Cholestat
Coledis
Colemin
Corolin
Denan
Eucor
FLOLIPID
Kolestevan
Labistatin
LACERSA
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
Medipo
MK-0733
MK-733
MK-733|Zocor®
Modutrol
Nivelipol
Nor-vastina
Pantok
Pepstatin
RANZOLONT
|
Rechol
Rendapid
Simcor
Simovil
SIMVADOR
SIMVASTATIN
Simvastatin [Usan:Ban:Inn]
SIMVASTATIN HYDROXY ACID
Simvastatin lactone
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
SIV691
Sivastin
Statin
Synvinolin
Valemia
Vasotenal
Velostatin
Vytorin
Zocor
ZOCOR HEART-PRO
Zocord
|
|
27 |
|
Peginterferon alfa-2a |
Approved, Investigational |
Phase 4 |
|
198153-51-4 |
|
Synonyms:
PEGASYS
PEG-IFN alfa-2A
PEG-Interferon alfa-2A
PEGINTERFERON ALFA-2A
PEGYLATED IFN-ALPHA-2A
Pegylated Interfeaon alfa-2A
|
Pegylated interferon alfa-2a
Pegylated interferon alpha-2a
Pegylated-interferon alfa 2a
RO-258310000
ROFERON-A
|
|
28 |
|
Lactitol |
Approved, Investigational |
Phase 4 |
|
585-86-4 |
157355 |
Synonyms:
4-O-beta-D-Galactopyranosyl-D-glucitol
4-O-β-D-Galactopyranosyl-D-glucitol
D-Lactitol
Emportal
Importal
Lactitol
|
Lactitolum
Neda lactiv importal
Oponaf
Pizensy
WURCS=2.0/2,2,1/[H2122H][a2112h-1b_1-5]/1-2/a4-b1
|
|
29 |
|
Fenofibrate |
Approved |
Phase 4 |
|
49562-28-9 |
3339 |
Synonyms:
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoate 1-methylethyl ester
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester
Abbott brand OF procetofen
ABT-335
ABT-335|Lipantil®|Supralip®|Tricor®
AbZ brand OF procetofen
Aliud brand OF procetofen
Ankebin
Antara
Antara micronized procetofen
Anto brand OF procetofen
Apo feno micro
Apo fenofibrate
Apo-fenofibrate
Apo-feno-micro
Apotex brand OF procetofen
AZU, fenofibrat
Azupharma brand OF procetofen
Betapharm brand OF procetofen
Bouchara brand OF procetofen
CiL
Controlip
CT Arzneimittel brand OF procetofen
CT-Arzneimittel brand OF procetofen
Debat, fénofibrate
Durafenat
Elasterate
Elasterin
Fenobeta
Fenobrate
Fenofanton
Fenofibrat abz
Fenofibrat al
Fenofibrat azu
Fenofibrat FPH
Fenofibrat heumann
Fenofibrat hexal
Fenofibrat ratiopharm
Fenofibrat stada
Fenofibrat von CT
FENOFIBRATE
Fénofibrate debat
Fénofibrate MSD
FENOFIBRATO
Fenofibrato [INN-Spanish]
Fenofibrat-ratiopharm
FENOFIBRATUM
Fenofibratum [INN-Latin]
Fenofibric acid
FENOGAL
FENOGLIDE
Fenotard
Finofibrate
Finofibric acid
FNF
Fournier brand OF procetofen
gate Brand OF procetofen
Gen fenofibrate
Gen-fenofibrate
Genpharm brand OF procetofen
GNR Pharma brand OF procetofen
GNR-Pharma brand OF procetofen
Heumann brand OF procetofen
Heumann, fenofibrat
Hexal brand OF procetofen
Hexal, fenofibrat
Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate
Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionic acid
Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate
|
Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionic acid
Knoll brand OF procetofen
Lichtenstein brand OF procetofen
Lipanthyl
Lipantil
LIPANTIL (TN)
LIPANTIL MICRO 200
LIPANTIL MICRO 267
LIPANTIL MICRO 67
Liparison
Lipidex
Lipidil
Lipidil Micro
Lipidil Supra
Lipidil ter
Lipidil-ter
Lipifen
Lipirex
Lipoclar
Lipofen
Lipofene
Liposit
Lipsin
Livesan
Lofibra
Luxacor
Merck dura brand OF procetofen
Micronized procetofen, antara
MTW Brand OF procetofen
MTW Fenofibrat
MTW-Fenofibrat
Nolipax
Normalip
Novartis brand OF procetofen
Novo fenofibrate
Novo-fenofibrate
Novopharm brand OF procetofen
NSC-281319
Nu fenofibrate
Nu pharm brand OF procetofen
Nu-fenofibrate
Nu-pharm brand OF procetofen
Pharmascience brand OF procetofen
Phenofibrate
PMS Fenofibrate micro
PMS-Fenofibrate micro
Procetofen
Procetofen reliant brand
Procetofen, antara micronized
Procetofene
Proctofene
Protolipan
Q Pharm brand OF procetofen
Q-Pharm brand OF procetofen
Ratiopharm brand OF procetofen
Reliant brand OF procetofen
Schering plough brand OF procetofen
Schering-plough brand OF procetofen
Secalip
Sedufen
Stada, fenofibrat
Stadapharm brand OF procetofen
Supralip
SUPRALIP 160
Tricor
TRICOR (TN)
Triglide
Trilipix
United drug brand OF procetofen
|
|
30 |
|
Voriconazole |
Approved |
Phase 4 |
|
137234-62-9 |
71616 |
Synonyms:
(AlphaR,betas)-a-(2,4-difluorophenyl)-5-fluoro-b-methyl-a(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(AlphaR,betas)-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-a-(2,4-difluorophenyl)-5-fluoro-b-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(αR,βS)-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
|
UK-109496
VCZ
Vfend
Voriconazol
Voriconazole
Voriconazolum
|
|
31 |
|
Nifedipine |
Approved |
Phase 4 |
|
21829-25-4 |
4485 |
Synonyms:
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester
Adalat
Adalat 10
Adalat 20
Adalat 5
ADALAT A.R.
ADALAT CC
Adalat CR
Adalat Crono
Adalat Ft
Adalat Gits
Adalat Gits 30
ADALAT IC
Adalat LA
ADALAT LA 20
ADALAT LA 30
ADALAT LA 60
Adalat LP
Adalat Oros
Adalat PA
ADALAT RET
Adalat Retard
Adalat®|BAY-A-1040|Procardia®
Adalate
ADALATE LP
ADANIF XL
Adapine
Adapress
Adcock ingram brand OF nifedipine
ADIPINE
ADIPINE MR 10
ADIPINE MR 20
ADIPINE XL
Afeditab CR
Alat
Aldipin
Alfadal
Alonix
Alonix S
Alpha-Nifedipine Retard
ANGIOPINE 10
ANGIOPINE 40 LA
ANGIOPINE 5
ANGIOPINE MR 10
ANGIOPINE MR 20
Angipec
Anifed
Anpine
Apo-Nifed
Aprical
AWD pharma brand OF nifedipine
BAY a 1040
BAY-a-1040
Bayer brand OF nifedipine
Bonacid
CALANIF
CALCHAN MR 10
CALCHAN MR 20
Calcibloc
Calcigard
CALCILAT
Camont
Cardifen
Cardilat
CARDILATE MR
Cardionorm
Chronadalate
Chronadalate Lp
Citilat
Coracten
CORACTEN SR
CORACTEN XL
Coral
Cordafen
Cordaflex
Cordalat
Cordicant
Cordilan
Cordipin
Cordipine
Corinfar
CORODAY MR
Corotrend
Corynphar
Depin
Dignokonstant
Dilafed
Dilcor
Dipinkor
Duranifin
Ecodipi
Ecodipin
Ecodipin E
|
Fedcor
Fedcor Retard
Fenamon
Fenamon Sr
Fenigidin
Fenihidin
Fenihidine
FORTIPINE LA40
GENALAT 10 RET
GENALAT 20 RET
Glopir
Hadipin
Hexadilat
HYPOLAR RET 10
HYPOLAR RET 20
HYPOLAR XL 30
Introcar
KENTIPINE
KENTIPINE MR 10
KENTIPINE MR 20
Kordafen
Korinfar
KRKA brand OF nifedipine
Macorel
Megalat
Monohydrochloride, nifedipine
Myogard
N1fedilat
Nedipin
NEOZIPINE XL
Nicardia
Nifangin
Nifar
Nifdemin
Nifebene
Nifecard
Nifecor
Nifedepat
Nifedicor
Nifedin
Nifedine
NIFEDIPINE
Nifedipine bayer brand
Nifedipine gtis
Nifedipine krka brand
Nifedipine monohydrochloride
Nifedipine orion brand
Nifedipine pfizer brand
Nifedipine Retard
Nifedipine-gtis
Nifedipino
Nifedipinum
Nifedipres
NIFEDIPRESS MR 10
NIFEDIPRESS MR 20
Nifedirex LP
NIFEDOTARD 20 MR
Nifelan
Nifelat
Nifelat Q
Nifelate
NIFELEASE
NIFENSAR XL
NIFE-WOLFF
Nificard
Nifidine
Nifipen
NIFOPRESS MR
NIFOPRESS RET
NIMODREL MR 10
NIMODREL MR 20
NIMODREL XL
Niphedipine
NIVATEN RET
Orion brand OF nifedipine
Orix
Oxcord
Pfizer brand OF nifedipine
Pidilat
Procardia
Procardia XL
Sepamit
SLOFEDIPINE XL 30
SLOFEDIPINE XL 60
TENSIPINE MR 10
TENSIPINE MR 20
Tibricol
UNIPINE XL
VALNI 20 RET
VALNI XL
VASAD
Vascard
Zenusin
|
|
32 |
|
Candesartan cilexetil |
Approved |
Phase 4 |
|
145040-37-5 |
|
Synonyms:
1-(Cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
Amias
Atacand
Blopress
CANDESARTAN
|
Candesartan cilexetil
Kenzen
Parapres
RATACAND
TCV 116
TCV-116
|
|
33 |
|
Ceftriaxone |
Approved |
Phase 4 |
|
73384-59-5 |
5479530 |
Synonyms:
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Anhydrous ceftriaxone sodium
Benaxona
Biotrakson
Boehringer mannheim brand OF ceftriaxone sodium
C18H18N8O7S3
Cefatriaxone
Cefaxona
Ceftrex
Ceftriaxon
Ceftriaxon curamed
Ceftriaxon hexal
Ceftriaxona
Ceftriaxona [INN-Spanish]
Ceftriaxona andreu
Ceftriaxona LDP torlan
CEFTRIAXONE
Ceftriaxone irex
Ceftriaxone sodium
Ceftriaxone sodium, anhydrous
Ceftriaxone, disodium salt
Ceftriaxone, disodium salt, hemiheptahydrate
Ceftriaxonum
|
Ceftriaxonum [INN-Latin]
Ceftriazone
Columbia brand OF ceftriaxone
CTRX
Curamed brand OF ceftriaxone sodium
FIDATO
Fustery brand OF ceftriaxone sodium
Galen brand OF ceftriaxone sodium
Hexal brand OF ceftriaxone sodium
Hoffman la roche brand OF ceftriaxone sodium
Hoffman-la roche brand OF ceftriaxone sodium
Inibsa brand OF ceftriaxone sodium
Irex brand OF ceftriaxone
Lendacin
Longacef
Longaceph
Pisa brand OF ceftriaxone sodium
Rocefalin
Rocefin
Rocephin
Rocephine
Roche brand OF ceftriaxone sodium
Sodium, ceftriaxone
Syntex brand OF ceftriaxone sodium
Tacex
Terbac
|
|
34 |
|
Liraglutide |
Approved |
Phase 4 |
|
204656-20-2 |
44147092 16134956 |
Synonyms:
ARG34LYS26-(N-Ε-(Γ-GLU(N-Α-HEXADECANOYL)))-GLP-1[7-37]
LIRAGLUTIDA
LIRAGLUTIDE
Liraglutide (genetical recombination)
Liraglutide (rDNA origin)
LIRAGLUTIDE RECOMBINANT
LIRAGLUTIDUM
N²⁶-(HEXADECANOYL-GAMMA-GLUTAMYLE)-[34-ARGININE]GLP-1-(7-37)-PEPTIDE
N²⁶-(N-HEXADECANOYL-L-GAMMA-GLUTAMYL)-[34-L-ARGININE]GLUCAGON-LIKE PEPTIDE 1-(7-37)-PEPTIDE
NN 2211
|
NN2211
NN-2211
NN-2211|NN2211|Victoza®
NN9924
NN-9924
NNC 90-1170
NNC-90-1170
SAXENDA
VICTOZA
|
|
35 |
|
Mefloquine |
Approved, Investigational |
Phase 4 |
|
53230-10-7 |
4046 |
Synonyms:
[(R*,S*)-2,8-BIS(TRIFLUOROMETHYL)QUINOLIN-4-YL]-(2-PIPERIDYL)METHANOL
a-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
GNF-PF-5544
GNF-Pf-5544|Lariam®|Ro-21-5998-001|WR-142490
Hoffmann la roche brand OF mefloquine hydrochloride
Hoffmann-la roche brand OF mefloquine hydrochloride
Lariam
MEFAQUIN
MEFLOQUIN
MEFLOQUINA
Mefloquine
|
MÉFLOQUINE
Mefloquine aziridine
Mefloquine HCL
Mefloquine hydrochloride
Mefloquinone
MEFLOQUINUM
Mephloquine
RO-215998
Roche brand OF mefloquine hydrochloride
WR-142490
Α-2-piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
|
|
36 |
|
Piperaquine |
Approved, Experimental, Investigational |
Phase 4 |
|
4085-31-8 |
|
Synonyms:
1,3-Bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-Bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
1,3-Bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane
|
PIPERAQUINE
Piperaquinoline
|
|
37 |
|
Sofosbuvir |
Approved |
Phase 4 |
|
1190307-88-0 |
45375808 |
Synonyms:
GI 7977
GI-7977
GS7977
GS-7977
ISOPROPYL (2S)-2-{[(S)-{[(2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL]METHOXY}(PHENOXY)PHOSPHORYL]AMINO}PROPANOATE
PSI 7977
|
PSI-7977
PSI-7977, GS-7977
S)-ISOPROPYL 2-((S)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)- (PHENOXY)PHOSPHORYLAMINO)PROPANOATE
SOFOSBUVIR
SOVALDI
|
|
38 |
|
Sumatriptan |
Approved, Investigational |
Phase 4 |
|
103628-46-2 |
5358 |
Synonyms:
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulphonamide
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulphonamide
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulphonamide
3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide
3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulphonamide
estradiol
Glaxo wellcome brand OF sumatriptan
GR-43175C
GR-43175C|Imigran®|Tosymra® (nasal spray)
GSK Brand OF sumatriptan
Imigran
Imigran recovery
|
Imitrex
Imitrex Oral
N02CC01
NP101
Succinate, sumatriptan
Sumatran
SUMATRIPTAN
SUMATRIPTÁN
Sumatriptan GSK brand
Sumatriptan succinate
Sumatriptanum
Sumatriptanum [INN-Latin]
Sumax
TOSYMRA
TRIPTAN
|
|
39 |
|
Halofantrine |
Approved |
Phase 4 |
|
69756-53-2 |
37393 |
Synonyms:
1-(1,3-dichloro-6-Trifluoromethyl-9-phenanthryl)-3-di(N-butyl)aminopropanol HCL
Halfan
Halfan®|WR-171669
Halofantrina
|
Halofantrine
Halofantrine hydrochloride
Halofantrinum
|
|
40 |
|
Parathyroid hormone |
Approved, Investigational |
Phase 4 |
|
9002-64-6 |
|
Synonyms:
ALX1-11
ALX-111
ALX-1-11
NPSP558
NPSP-558
Parathormone
Parathormone (human recombinant)
Parathyrin
PARATHYROID HORMONE
Parathyroid hormone (1-84) human recombinant
|
Parathyroid hormone (rDNA)
PAROIDIN
PREOTACT
PTH
PTH(1-84)
rhPTH
rhPTH(1-84)
rPTH
rPTH(1-84)
|
|
41 |
|
Canagliflozin |
Approved |
Phase 4 |
|
842133-18-0 |
74323022 24812758 |
Synonyms:
1-(GLUCOPYRANOSYL)-4-METHYL-3-(5-(4-FLUOROPHENYL)-2-THIENYLMETHYL)BENZENE
CANAGLIFLOZIN
CANAGLIFLOZIN ANHYDROUS
Canagliflozina
Invokana®|JNJ-28431754|TA-7284
|
JNJ-24831754-ZAE
JNJ-28431754
JNJ-28431754-AAA
TA-7284
|
|
42 |
|
Oseltamivir |
Approved |
Phase 4 |
|
204255-11-8, 196618-13-0 |
65028 |
Synonyms:
(-)-Oseltamivir
(−)-OSELTAMIVIR
(3R,4R,5S)-4-ACETAMIDO-5-AMINO-3-(PENTAN-3-YLOXY)CYCLOHEX-1-ENECARBOXYLIC ACID
1-CYCLOHEXENE-1-CARBOXYLIC ACID, 4-(ACETYLAMIDO)-5-AMINO-3-(1-ETHYLPROPOXY)-, ETHYL ESTER, (3R-(3ALPHA,4BETA,5ALPHA))-
4-ACETYLAMIDO-5-AMINO-3-(1-ETHYL-PROPOXY)-CYCLOHEX-1-ENECARBOXYLIC ACID
Agucort
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid
FLUVIR
GS 4104
GS-4071 ETHYL ESTER
GS4104
GS-4104
|
HSDB 7433
LDD852
OSELTAMIVIR
OSÉLTAMIVIR
OSELTAMIVIR ACID
OSELTAMIVIR CARBOXYLATE
Oseltamivir phosphate
Oseltamivirum
RO64-0796
RO-640796
RO-64-0796
Tamiflu
|
|
43 |
|
Lumiracoxib |
Approved, Investigational |
Phase 4 |
|
220991-20-8 |
151166 |
Synonyms:
2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetate
2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid
COX 189
COX189
COX-189
|
LUMIRACOXIB
Lumiracoxibum
Prexige
Prexige®
|
|
44 |
|
Ledipasvir |
Approved |
Phase 4 |
|
1256388-51-8 |
67505836 |
Synonyms:
GS 5885
GS5885
GS-5885
LEDIPASVIR
|
Lédipasvir
LEDIPASVIR ACETONATE
Ledipasvirum
WHO 9796
|
|
45 |
|
Ranolazine |
Approved, Investigational |
Phase 4 |
|
142387-99-3, 95635-55-5 |
56959 |
Synonyms:
(-)-Ranolazine
CVT-303
Dihydrochloride, ranolazine
HCL, Ranolazine
Hydrochloride, ranolazine
N-(2,6-DIMETHYLPHENYL)-2-[4-[2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL]PIPERAZIN-1-YL]ACETAMIDE
N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
Ranexa
Ranolazina
|
Ranolazine
Ranolazine 2HCL
Ranolazine dihydrochloride
Ranolazine HCL
Ranolazine hydrochloride
Renolazine
RS-43285
RS-43285-003
|
|
46 |
|
Sodium sulfate |
Approved, Vet_approved |
Phase 4 |
|
7757-82-6 |
|
Synonyms:
Anhydrous sodium sulfate
Disodium sulfate
Disodium sulfuric acid
Disodium sulphate
Disodium sulphuric acid
Mangxiao
Mirabilitum
Na2SO4
Natrii sulphas
Natriumsulfat
Natriumsulphat
Puxiao
Salt cake
Sodium bisulfate
Sodium bisulfate, monohydrate
Sodium hydrosulfate
Sodium sulfate anhydrous
|
Sodium sulfate, 35S-labeled CPD
Sodium sulfate, anhydrous
Sodium sulfate, decahydrate
Sodium sulfate, dried
Sodium sulfuric acid
Sodium sulfuric acid, anhydrous
Sodium sulfuric acid, dried
Sodium sulphate
Sodium sulphate anhydrous
Sodium sulphate, anhydrous
Sodium sulphate, dried
Sodium sulphuric acid
Sodium sulphuric acid, anhydrous
Sodium sulphuric acid, dried
Sulfuric acid disodium salt, anhydrous
Sulfuric acid, monosodium salt
Thenardite
|
|
47 |
|
Lubiprostone |
Approved, Investigational |
Phase 4 |
|
136790-76-6 |
656719 157920 |
Synonyms:
0211, SPI
7-[(2R,4AR,5S,7ar)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-octahydrocyclopenta[b]pyran-5-yl]heptanoate
Amitiza
Amitiza®|SPI-0211
|
Lubiprostone
RU-0211
SPI-0211
|
|
48 |
|
Iodine |
Approved, Investigational |
Phase 4 |
|
7553-56-2 |
807 |
Synonyms:
Cadex
Diiodine
I2
Iode
Iodine
Iodine 127
Iodine-127
Iodine-molecule
|
Iodio
iodo
Iodum
Jod
Jood
Molecular iodine
NSC-42355
Tincture iodine
|
|
49 |
|
Cilostazol |
Approved, Investigational |
Phase 4 |
|
73963-72-1 |
2754 |
Synonyms:
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
CILOSTAZOL
Cilostazole
Cilostazolum
|
Cilostazolum [INN-Latin]
OPC-13013
OPC-13013|OPC-21|Pletal®
OPC-21
Pletaal
Pletal
|
|
50 |
|
Capsaicin |
Approved |
Phase 4 |
|
404-86-4 |
1548943 |
Synonyms:
(e)8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide(8CL)
8 Methyl N vanillyl 6 nonenamide
8-Methyl-N-vanillyl-6-nonenamide
Alacan brand OF capsaicin
ALGRX 4975
ALGRX-4975
Antiphlogistine rub a-535 capsaicin
Axsain
CAPSAICIN
Capsaicina
Capsaicine
Capsicum farmaya
Capsidol
Capsin
Capzasin
Carter horner brand OF capsaicin
Centrum brand OF capsaicin
e-Capsaicin
Elan brand OF capsaicin
epsilon-Capsaicin
FEMA NO. 3404
Flemming brand OF capsaicin
|
Gelcen
Isodecenoate
Isodecenoate vanillylamide
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
Link brand OF capsaicin
Medicis brand OF capsaicin
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
NGX-1998
NGX-4010
NSC-56353
QUTENZA
Qutenza®
Smaller brand OF capsaicin
Styptysat
Thompson brand OF capsaicin
trans-8-Methyl-N-vanillyl-6-nonenamide
Transacin
Vinas brand OF capsaicin
Zacin
Zostrix
ZOSTRIX HP
|
|
Interventional clinical trials:
(show top 50)
(show all 27548)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Prospective Randomized Study to Evaluate the Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg vs. 6mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen |
Unknown status |
NCT03088280 |
Phase 4 |
Thymoglobulin |
2 |
Effect of Perineural Dexmedetomidine on the ED50 Ropivacaine for Brachial Plexus Blocks in Pediatric Patients: a Randomized Trial |
Unknown status |
NCT02781246 |
Phase 4 |
perineural dexmedetomidine |
3 |
The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients Taking Low-dose Aspirin, A Pilot Study |
Unknown status |
NCT01397240 |
Phase 4 |
Albis Tab;Placebo |
4 |
Comparison of High-dose Furosemide Versus the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure |
Unknown status |
NCT00937092 |
Phase 4 |
Furosemide;low-dose dopamine + low-dose furosemide |
5 |
Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia |
Unknown status |
NCT01010516 |
Phase 4 |
High-dose rosuvastatin;Statin plus fenofibrate;Statin plus niacin ER/laropiprant |
6 |
Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial) Comparison of the Efficacy and Safety of Biostable Polymer DES (Promus PremierTM, Xience Alpine®, and Resolute Onyx®) With Biodegradable Polymer DES (Biomatrix®, Biomatrix Flex®, Nobori®, Ultimaster®,Synergy®, and Orsiro®)and Conventional Dose Prasugrel Therapy With Reduced Dose Prasugrel Therapy in Acute Coronary Syndrome Patients Treated With Percutaneous Coronary Intervention |
Unknown status |
NCT02193971 |
Phase 4 |
Prasugrel 5mg |
7 |
Low Dose Versus High Dose Steroids in Treatment of Viral Encephalitis |
Unknown status |
NCT04103684 |
Phase 4 |
Methylprednisolone;Dexamethasone |
8 |
GLM Dose Optimisation to Adequate Levels to Achieve Response in Colitis (GOAL-ARC). A Nationwide Multi-centred Randomised Controlled Trial (RCT) Investigating the Use of GLM Dose Adjustment in Ulcerative Colitis (UC). |
Unknown status |
NCT02687724 |
Phase 4 |
Golimumab (GLM) |
9 |
Comparison of Low-dose Heparin Versus Standard Dose Heparin During Coronary Interventions (DEDICA Trial) |
Unknown status |
NCT01694459 |
Phase 4 |
Low-dose heparin;Standard dose heparin |
10 |
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine |
Unknown status |
NCT02297542 |
Phase 4 |
|
11 |
To Evaluate Prevention Effect Of Everolimus and Low-dose Tacrolimus in Comparison With Standard-dose Tacrolimus Therapy With Mycophenolic Acid on the New Onset Diabetes Mellitus After Transplantation in the Renal Allograft Recipients |
Unknown status |
NCT02036554 |
Phase 4 |
Everolimus;Tacrolimus;Mycophenolic acid |
12 |
A Prospective, Randomized, 3-arm Parallel Trial to Evaluate the Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Treatment |
Unknown status |
NCT00498680 |
Phase 4 |
Sildenafil, Vardenafil;Sildenafil;Vardenafil;Sildenafil & Vardenafil |
13 |
A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients |
Unknown status |
NCT04101708 |
Phase 4 |
Lansoprazole, Amoxicillin;Lansoprazole, Amoxicillin,Clarithromycin and Bismuth subcitrate |
14 |
Randomized Comparison of Fixed Low-dose Combination of THREE Antihypertensive Drugs Versus Fixed High-dose Combination of Two Antihypertensive Drugs in Arterial Hypertension (the 3D Trial) |
Unknown status |
NCT02710552 |
Phase 4 |
Tripliam (perindopril, indapamide, amlodipine);Reaptan (perindopril, amlodipine) |
15 |
a Comparative Study of Aspirin Either at Fixed Dose or at a Dose Titrated by Platlet Function Analyzer(PFA-100) vs Placebo in Primary Prevention of Vascular Access for Hemodialysis |
Unknown status |
NCT02055131 |
Phase 4 |
aspirin |
16 |
The Optimal Dose Of Dexamethasone To Be Used As An Adjuvant To Low Volume Bupivacaine Ultrasound Guided Supraclavicular Brachial Plexus Block. A Randomized Controlled Double Blinded Dose Ranging Study |
Unknown status |
NCT03043495 |
Phase 4 |
Dexamethasone |
17 |
A Randomized Comparison of Low-dose Versus High-dose Rosuvastatin on Optical Coherence Tomography Based Early Vascular Healing for Patients With Acute Coronary Syndrome |
Unknown status |
NCT03007524 |
Phase 4 |
High dose Rosuvastatin;Low dose Rosuvastatin |
18 |
Split-dose Versus Single-dose Polyethylene Glycol Regimen for Capsule Endoscopy Is Timing of Preparation for Capsule Endoscopy the Key for the Best Small-bowel Cleansing? |
Unknown status |
NCT02396017 |
Phase 4 |
Polyethylene Glycol |
19 |
A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post Operative Opioid Use Disorder Symptoms |
Unknown status |
NCT03266445 |
Phase 4 |
buprenorphine/naloxone |
20 |
A Randomized, Two-Way Crossover, Single-Dose Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product (Nexium Powder for Injection and Infusion 40 mg) in Healthy Adult Subjects |
Unknown status |
NCT02444507 |
Phase 4 |
Nexium powder for injection and infusion 40 mg;Esomelone Powder for Solution for Injection / Infusion 40 mg |
21 |
An Immunogenicity and Safety Study of Combined Adsorbed Tetanus, Low Dose Diphtheria and Acellular Pertussis Vaccine (Td5ap and Td1aP) Given as a School-leaving Booster to 14-15-year-old Children Primed With a Five Component Acellular Pertussis Vaccine at 3, 5 and 12 Months of Age, and a Booster Dose at 5½ Years of Age |
Unknown status |
NCT00870350 |
Phase 4 |
|
22 |
Comparative Effectiveness and Safety Analysis of Low-dose and Standard-dose Ticagrelor in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention |
Unknown status |
NCT03381755 |
Phase 4 |
half-dose ticagrelor;standard-dose ticagrelor |
23 |
International Multicenter Trial for the Evaluation of a Four-Drug Fixed Dose Combined Tablet Daily in the Initial Intensive Phase of Chemotherapy Followed by a Two-Drug Fixed Dose Combined Tablet Three Times a Week in the Continuation Phase for the Treatment of Pulmonary Tuberculosis |
Unknown status |
NCT00216333 |
Phase 4 |
combined fixed dose combination |
24 |
Immunologic Response of Hepatitis B Single Dose Versus 3-dose Series in Previously Vaccinated HIV-infected Adults at Maharaj Nakorn Chiang Mai Hospital: A Randomized Controlled Trial |
Unknown status |
NCT03219203 |
Phase 4 |
|
25 |
A Prospective, Randomised, Open-labeled, Parallel Group Study to Assess the Efficacy and Safety of Low Dose Ticagrelor Compared With Standard Dose Ticagrelor in Patients With Unstable Angina Pectoris After Drug Eluting Stent Implantation |
Unknown status |
NCT03620760 |
Phase 4 |
Ticagrelor 90 mg;Ticagrelor 45 mg;Aspirin |
26 |
Optimal Dose of Ticagrelor(90 mg qd)and Double Standard-dose Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With Coronary Heart Disease |
Unknown status |
NCT03614832 |
Phase 4 |
Ticagrelor 90 mg;Clopidogrel 150 mg |
27 |
LOW CYCLO: A Multicenter, Prospective, Randomized Study Evaluating the Benefit, on Renal Function, of Two Doses of Ciclosporine: Low Dose Versus Usual Dose, in Association With Mycophenolate and Corticoïds, in de Novo Cardiac Transplant |
Unknown status |
NCT00159159 |
Phase 4 |
Ciclosporine 130 µg/l < T0 ciclosporinemia < 200 µg/l;Ciclosporine 200 µg/l < T0 ciclosporinemia < 300 µg/l |
28 |
A Randomized Control Trial Comparing 4L PEGlyte to Regular Dose Pico-Salax and Split Dose Pico-Salax for Colonoscopy Bowel Preparation in Hospitalized Patients |
Unknown status |
NCT01627171 |
Phase 4 |
Bisacodyl 10mg;Polyethelene Glycol;Picosulfate sodium |
29 |
High Dose Versus Low Dose Heparinization in Patients Undergoing Offpump Coronary Artery Bypass |
Unknown status |
NCT02812355 |
Phase 4 |
Heparin |
30 |
Intraoperative Tranexamic Acid Infusion in Low Dose Versus in High Dose for Reducing Blood Loss and Its Effect on Postoperative Thromboembolic Complications in Radical Cystectomy Operations |
Unknown status |
NCT04537533 |
Phase 4 |
Tranexamic acid |
31 |
A Pilot Study to Evaluate the Efficacy of Fixed Dose Combination Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel Alone Versus Fixed Dose Combination Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel Plus Benzoyl Peroxide 6% Foaming Cloths in the Treatment of Facial Acne Vulgaris |
Unknown status |
NCT01422785 |
Phase 4 |
clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths |
32 |
A Double Blind Study Comparing Low Dose and High Dose IV Esomeprazole After Successful Endoscopic Therapy in Patients With Peptic Ulcer Bleeding |
Unknown status |
NCT01275937 |
Phase 4 |
Esomeprazole;esomeprazole |
33 |
A Prospective, Randomized, 3-arm Parallel Trial to Evaluate the Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Treatment |
Unknown status |
NCT01364701 |
Phase 4 |
Sildenafil 100 mg;Tadalafil 20 mg;Combination half of maximal dose for sildenafil & tadalafil |
34 |
Effectiveness and Safety of Low-dose vs. High-dose Rosuvastatin on Long-term Cardiovascular Events in Korean Patients After Percutaneous Coronary Intervention: 30-month, Prospective, Single-center, Randomized Trial |
Unknown status |
NCT02859480 |
Phase 4 |
Rosuvastatin 5mg;Rosuvastatin 20mg |
35 |
Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage |
Unknown status |
NCT01917799 |
Phase 4 |
Aspirin;Heparin |
36 |
Double-blind Randomized Controlled Clinical Trial of Low-dose Lenalidomide in the Treatment of COVID-19 Disease |
Unknown status |
NCT04361643 |
Phase 4 |
Lenalidomide as a 5 mg capsule PO daily, days 1, 3, and 5.;Placebo |
37 |
Does Bowel Preparation (Either as a Single or Divided Dose) Produce Better Cleansing and Diagnostic Yield Than no Preparation at All in Small Bowel Capsule Endoscopy |
Unknown status |
NCT03351972 |
Phase 4 |
Klean Prep |
38 |
Preoperative, Single-dose Intravenous Iron Formulation to Reduce Post-surgical Complications in Patients Undergoing Major Abdominal Surgery: a Pilot Randomised Control Trial (PIRCAS Trial - Pilot) |
Unknown status |
NCT03295851 |
Phase 4 |
Ferric carboxymaltose;Ferrous Fumarate |
39 |
Low Dose Statins, Ezetimibe and Nutraceuticals in Coronary Artery Disease Patients Intolerant to High Intensity Statin Treatment (TArget ChOlesterol) |
Unknown status |
NCT03277079 |
Phase 4 |
statin + ezetimibe;statin + ezetimibe + Nutraceuticals |
40 |
Nanoparticle Albumin-Bound Paclitaxel Followed by Dose-Intensive Epirubicin in Combination With Cyclophosphamide as Neoadjuvant Chemotherapy in Triple Negative Breast Cancer |
Unknown status |
NCT03799679 |
Phase 4 |
Chemotherapeutic Agent |
41 |
A Randomized Comparison of Transitioning From Insulin GLargine to Insulin Degludec usING a Bridging Dose of Glargine Versus Direct Conversion, in Patients With Type 1 Diabetes Mellitus - a Pilot Study |
Unknown status |
NCT04623086 |
Phase 4 |
Insulin Degludec;Insulin Glargine;Placebo |
42 |
Evaluation of High-dose Corticosteroids on Microcirculation Alterations in Cardiac Surgery, by FMD (Flow Mediated vasoDilation), Near Infrared Spectrophotometry (NIRS) and Biological Analysis (Syndecan-1) |
Unknown status |
NCT02798068 |
Phase 4 |
Solu-medrol or placebo administration |
43 |
Paroxetines Effect on Tramadols Metabolism and Pharmakodynamics: a Dose Response Study |
Unknown status |
NCT00785603 |
Phase 4 |
Paroxetine;Paroxetin placebo;Tramadol |
44 |
The Bucillamine Study of Holding Remission After Infliximab Dose-off in Patients With Rheumatoid Arthritis Receiving Methotrexate |
Unknown status |
NCT00716248 |
Phase 4 |
bucillamine;methotrexate |
45 |
Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine |
Unknown status |
NCT02146469 |
Phase 4 |
|
46 |
Single Dose rATG for Treatment of Acute Renal Allograft Rejection |
Unknown status |
NCT02102854 |
Phase 4 |
rATG |
47 |
The Compare the Effect of Peroperative Intravenous Single Dose Dexamethasone and the Addition of Dexamethasone to Femoral Nerve Block on Postoperative Analgesic Consumption Anf Patient Comfort in Unilateral Total Knee Arthroplasty Patients |
Unknown status |
NCT02090790 |
Phase 4 |
iv dexamethasone;femoral dexamethasone;serum physiologic |
48 |
The Effect of Single Dose of Atorvastatin on Change of Circulating Endothelial Microparticles |
Unknown status |
NCT02023892 |
Phase 4 |
atorvastatin;placebo |
49 |
Randomized Trial of the Association Between Low-Dose Statins and Nutraceuticals in High-intEnsity Statin-intoleRant patiENts With Very High Risk Coronary Artery diseasE |
Unknown status |
NCT02001883 |
Phase 4 |
Association low-dose statin and nutraceuticals |
50 |
Study on Half-dose Photodynamic Therapy Versus Eplerenone in Chronic CenTRAl Serous Chorioretinopathy (SPECTRA Trial) |
Unknown status |
NCT03079141 |
Phase 4 |
Eplerenone |
|